Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9812911 | 0.82 | PIK3CD (0.40) | PIK3CDALDH1A1KDM4EHSD17B10L3MBTL1 | |
| SCHEMBL4281691 | 0.82 | ADH1A (0.48) | PIK3CDALDH1A1KDM4EHSD17B10L3MBTL1 | |
| SCHEMBL9728254 | 0.82 | PIK3CD (0.42) | PIK3CDALDH1A1KDM4EHSD17B10L3MBTL1 | |
| SCHEMBL9462350 | 0.80 | ADH1A (0.47) | PIK3CDALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL628951 | 0.79 | L3MBTL1 (0.42) | PIK3CDALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL13135422 | 0.78 | KMT2A (0.41) | PIK3CDALDH1A1KDM4EHSD17B10KMT2A | |
| SCHEMBL658992 | 0.78 | L3MBTL1 (0.50) | PIK3CDALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL13911314 | 0.78 | ADH1A (0.44) | PIK3CDALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL18711467 | 0.77 | DPP4 (0.41) | PIK3CDALDH1A1KDM4EHSD17B10LMNA | |
| SCHEMBL9632418 | 0.77 | THRA (0.43) | ADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902392-B2 | Method for the production of organosilicon compounds comprising carboxy radicals | WACKER CHEMIE AG (DE) | 2011-03-08 | — | — | US | disclosed |
| US-20090221842-A1 | METHOD FOR THE PRODUCTION OF ORGANOSILICON COMPOUNDS COMPRISING CARBOXY RADICALS | WACKER CHEMIE AG (DE) | 2009-09-03 | — | — | US | disclosed |
| EP-1737872-B1 | METHOD FOR THE PRODUCTION OF ORGANOSILICON COMPOUNDS COMPRISING CARBOXY RADICALS | WACKER CHEMIE AG (DE) | 2007-08-15 | — | — | EP | disclosed |
| EP-1737872-A1 | METHOD FOR THE PRODUCTION OF ORGANOSILICON COMPOUNDS COMPRISING CARBOXY RADICALS | Wacker Chemie AG (DE) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005103060-A1 | METHOD FOR THE PRODUCTION OF ORGANOSILICON COMPOUNDS COMPRISING CARBOXY RADICALS | WACKER CHEMIE AG (DE) | 2005-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221842-A1 | METHOD FOR THE PRODUCTION OF ORGANOSILICON COMPOUNDS COMPRISING CARBOXY RADICALS | HAO2, CBR3, SOD3 | PIK3CD 4178/4885ALDH1A1 1595/4885KDM4E 2297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.